Oragenics, Inc. (OGEN)
0.5399
+0.02
(+3.81%)
USD |
NYAM |
Aug 26, 14:48
Oragenics 1 Year Total Returns (Daily) : -53.56% for Aug. 25, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 25, 2026 | -53.56% |
| August 24, 2026 | -52.77% |
| August 21, 2026 | -51.39% |
| August 20, 2026 | -50.00% |
| August 19, 2026 | -49.98% |
| August 18, 2026 | -50.36% |
| August 17, 2026 | -53.48% |
| August 14, 2026 | -55.22% |
| August 13, 2026 | -53.90% |
| August 12, 2026 | -54.16% |
| August 11, 2026 | -53.09% |
| August 10, 2026 | -52.76% |
| August 07, 2026 | -57.70% |
| August 06, 2026 | -58.51% |
| August 05, 2026 | -59.09% |
| August 04, 2026 | -56.35% |
| August 03, 2026 | -57.66% |
| July 31, 2026 | -60.32% |
| July 30, 2026 | -62.00% |
| July 29, 2026 | -63.48% |
| July 28, 2026 | -63.99% |
| July 27, 2026 | -63.96% |
| July 24, 2026 | -64.27% |
| July 23, 2026 | -64.92% |
| July 22, 2026 | -61.59% |
| Date | Value |
|---|---|
| July 21, 2026 | -59.09% |
| July 20, 2026 | -59.92% |
| July 17, 2026 | -61.57% |
| July 16, 2026 | -60.72% |
| July 15, 2026 | -58.21% |
| July 14, 2026 | -59.87% |
| July 13, 2026 | -59.86% |
| July 10, 2026 | -59.86% |
| July 09, 2026 | -59.41% |
| July 08, 2026 | -60.57% |
| July 07, 2026 | -62.84% |
| July 06, 2026 | -62.09% |
| July 02, 2026 | -59.38% |
| July 01, 2026 | -60.90% |
| June 30, 2026 | -84.80% |
| June 29, 2026 | -85.43% |
| June 26, 2026 | -83.18% |
| June 25, 2026 | -83.45% |
| June 24, 2026 | -83.75% |
| June 23, 2026 | -83.48% |
| June 22, 2026 | -84.16% |
| June 18, 2026 | -85.19% |
| June 17, 2026 | -86.04% |
| June 16, 2026 | -85.96% |
| June 15, 2026 | -85.69% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.73% |
| Alnylam Pharmaceuticals, Inc. | -45.88% |
| Anika Therapeutics, Inc. | 134.4% |
| Savara, Inc. | 78.34% |
| Vericel Corp. | 20.76% |